Analyst Reco.

Jun. 11 SB1 maintains buy rating on Novo Nordisk following industry conference FW
Jun. 09 NOVO NORDISK : Deutsche Bank reiterates its Neutral rating ZD
Jun. 09 NOVO NORDISK : JP Morgan sticks Neutral ZD
Jun. 08 NOVO NORDISK : JP Morgan remains Neutral ZD
Jun. 04 NOVO NORDISK : Goldman Sachs gives a Neutral rating ZD
Jun. 03 Goldman Sachs raises Novo Nordisk price target to DKK 305 (263), maintains Neutral rating - BN FW
May. 29 NOVO NORDISK : Jefferies remains Neutral ZD
May. 29 Jefferies Examines GLP-1 Compounding, Maintains Hold Rating on Novo Nordisk Zonebourse
May. 28 NOVO NORDISK : Deutsche Bank reiterates its Neutral rating ZD
May. 21 Bernstein Updates Novo Nordisk Price Target, Estimates After Wegovy Pill Launch Outperforms MT
May. 21 Bernstein raises price target for Novo Nordisk to DKK 200 (175), reiterates underperform - BN FW
May. 20 NOVO NORDISK : Deutsche Bank sticks Neutral ZD
May. 20 Intron: Novo Nordisk sales could decline in 2027 FW
May. 19 NOVO NORDISK : Barclays reiterates its Neutral rating ZD
May. 18 Novo Nordisk slides on signs of slowing sales momentum for Wegovy pill FW
May. 13 NOVO NORDISK : Jefferies reaffirms its Neutral rating ZD
May. 12 NOVO NORDISK : Bernstein keeps a Sell rating ZD
May. 11 Citi raises Novo Nordisk price target following strong Wegovy pill launch FW
May. 11 SB1: Market underestimates Novo Nordisk potential - raises price target FW
May. 11 SB1 Markets raises Novo Nordisk price target to DKK 350 (280), reiterates Buy FW
May. 11 Citigroup raises Novo Nordisk price target to DKK 290 (275), reiterates Neutral rating FW
May. 08 NOVO NORDISK : Deutsche Bank gives a Neutral rating ZD
May. 08 NOVO NORDISK : Gets a Neutral rating from JP Morgan ZD
May. 08 NOVO NORDISK : UBS sticks Neutral ZD
May. 08 NOVO NORDISK : Barclays sticks Neutral ZD
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!